Receptor | Background Drug | EC50,GABA (µM) | Value of L |
---|---|---|---|
βαγ+βα | None | 34 ± 8 | 9000a |
βαγ+βα | 5 µM Pro | 11 ± 1 | 1826 ± 904b |
βαγ+βα | 10 µM Pro | 1.2 ± 0.1 | 37 ± 4c |
βαγ+βα | 20 μM Pro | 0.50 ± 0.09 | 11 ± 4c |
βαγ+βα | 1 μM ALF | 3.3 ± 0.4 | 606 ± 161c |
βαγ+βα | 100 μM PEB | 1.1 ± 0.3 | 59 ± 16c |
βαγ+βα | 200 μM PEB | 0.43 ± 0.04 | 23 ± 6c |
βαγ+βα(L263S) | None | 3.0 ± 0.1 | 74 ± 9a |
βα(L263S)γ+βα | None | 2.0 ± 0.1 | 19 ± 2a |
βα(L263S)γ+βα(L263S) | None | 0.28 ± 0.04 | 7.3 ± 0.4a |
β(Y143W)αγ+β(Y143W)α | None | 2.4 ± 0.2 | 141 ± 20a |
β(Y143W)αγ+βα(L263S) | None | 0.70 ± 0.06 | 67 ± 5a |
β(Y143W)αγ+βα | 25 μM Pro | 0.46 ± 0.06 | 7.4 ± 1.5c |
βαγ+β(Y205S)α | none | 129 ± 16 | 9000d |
βαγ+β(Y205S)α | 5 μM Pro | 88 ± 9 | 539 ± 119c |
βαγ+β(Y205S)α | 10 μM Pro | 24 ± 2 | 315 ± 58c |
βαγ+β(Y205S)α | 20 μM Pro | 8.2 ± 2.0 | 42 ± 5c |
βαγ+β(Y205S)α | 40 μM Pro | 3.9 ± 0.5 | 11 ± 2c |
βα(L263S)γ+β(Y205S)α | None | 6.1 ± 1.4 | 35 ± 1a |
ALF, alfaxalone; PEB, pentobarbital; Pro, propofol.
↵a Based on the effect of picrotoxin on constitutive activity.
↵b Calculated from the current response in the presence of the background drug corrected for constitutive activity.
↵c Calculated from the current response in the presence of the background drug assuming no constitutive activity.
↵d Considered to equal that of the wild-type receptor.